"As your partner in health, we’re dedicated to making it easier for you to live well—so you can show up for the moments that matter most. To us, people are more than patients. We work together as a team to champion high-quality, low-cost care. Our providers and services span hospitals, clinics and at home settings across Iowa, Illinois and Wisconsin. Our presence in metropolitan and rural communities allows us to innovate through partnerships, organizations outside of healthcare, and our family of team members remains dedicated to shared values that put our people first. Because you matter to this world, and we’ll show you just how much."

During the past decade, Methodist West Hospital conducted 138 clinical trials. In the 10-year time frame, 138 clinical trials started and 77 clinical trials were completed, i.e. on average, 55.8% percent of trials that started reached the finish line to date. In the past 5 years, 71 clinical trials started and 50 clinical trials were completed. i.e. 70.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Methodist West Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 84 trials, followed by "Alliance for Clinical Trials in Oncology" with 43 trials sponsored, "SWOG Cancer Research Network" with 28 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "Gynecologic Oncology Group" with 21 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist West Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 116 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Methodist West Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Breast Cancer" (8 trials), "Invasive Breast Carcinoma" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Methodist West Hospital" in a lesser frequency.

Most popular intervention types in "Methodist West Hospital" are "Drug" (160 trials), "Other" (128 trials), "Biological" (80 trials), "Procedure" (55 trials) and "Radiation" (33 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (52 trials), "Quality-of-Life Assessment" (49 trials), "Questionnaire Administration" (38 trials), "Biospecimen Collection" (26 trials) and "Carboplatin" (25 trials). Other intervention names were less common.

The vast majority of trials in "Methodist West Hospital" are 158 trials for "All" genders, 40 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Methodist West Hospital". undefined are not yet recruiting, 65 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Methodist West Hospital, 5 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Methodist West Hospital, 6 "Phase 1" clinical trials were conducted, 99 "Phase 2" clinical trials and 98 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".